<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"
  dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
  <?SourceDTD.Version 1.2?>
  <?ConverterInfo.XSLTName jats2jats3.xsl?>
  <?ConverterInfo.Version 1?>
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="iso-abbrev">Pharmacophore</journal-id>
      <journal-id journal-id-type="publisher-id">pharmacophorejournal.com</journal-id>
      <journal-id journal-id-type="publisher-id">Pharmacophore</journal-id>
      <journal-title-group>
        <journal-title>Pharmacophore</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2229-5402</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">pharmacophorejournal.com-6663</article-id>
      <article-id pub-id-type="doi">10.51847/e4GvuoN96z</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Formulation, Evaluation, and Validation of Microspheres of Cyclophosphamide for Topical Delivery</article-title>
      </title-group>
                  <pub-date pub-type="epub">
        <day>27</day>
        <month>02</month>
        <year>2023</year>
      </pub-date>
      <volume>14</volume>
      <issue>1</issue>
      <fpage>1</fpage>
      <lpage>8</lpage>
      <permissions>
        <copyright-statement>
          Copyright: &#x000a9; 2026 Pharmacophore
        </copyright-statement>
        <copyright-year>2026</copyright-year>
        <license>
          <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/"
            specific-use="textmining" content-type="ccbyncsalicense">
            https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref>
          <license-p>This is an open access journal, and articles are distributed under the terms of
            the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows
            others to remix, tweak, and build upon the work non-commercially, as long as appropriate
            credit is given and the new creations are licensed under the identical terms.</license-p>
        </license>
      </permissions>
      <abstract>
        <title>A<sc>BSTRACT</sc></title>
        <p>Cyclophosphamideis a chemotherapy medication used to treat cancer. It is also used to suppress the immune system. The present investigation deals with the preparation of microspherescontaining cyclophosphamide. The method has been developed and validated for the estimation of cyclophosphamide using water as a diluent. The λ max of cyclophosphamide in water was found to be 263 nm. The parameters, range, linearity, accuracy, precision, LOD, LOQ, robustness, and ruggedness were determined. The drug cyclophosphamide showed linearity in the concentration range from 0.4-1.4μg/ml with a correlation coefficient value of 0.999. The proposed method was applied to pharmaceutical formulation and the percentage amount of drug estimated was found to be 99.3%. The accuracy of the method was checked by a percentage recovery experiment at three levels, i.e., 80%, 100%, and 120%. The percentage recovery was found to be in the range of 99±100%. The precision of the method was studied as day variation. The % RSD value within the official limit (</p>
      </abstract>
      <kwd-group>
              </kwd-group>
    </article-meta>
  </front>
</article>